nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—CYP2B6—Thiotepa—sarcoma	0.12	0.154	CbGbCtD
Desipramine—SLC22A5—Dactinomycin—sarcoma	0.117	0.15	CbGbCtD
Desipramine—SLC22A3—Vincristine—sarcoma	0.116	0.148	CbGbCtD
Desipramine—CYP2E1—Dacarbazine—sarcoma	0.0677	0.0866	CbGbCtD
Desipramine—CYP2E1—Mitoxantrone—sarcoma	0.0525	0.0672	CbGbCtD
Desipramine—CYP1A2—Dacarbazine—sarcoma	0.0391	0.0501	CbGbCtD
Desipramine—CYP3A4—Thiotepa—sarcoma	0.037	0.0474	CbGbCtD
Desipramine—CYP2E1—Etoposide—sarcoma	0.0331	0.0424	CbGbCtD
Desipramine—ABCB1—Dactinomycin—sarcoma	0.0297	0.038	CbGbCtD
Desipramine—ABCB1—Mitoxantrone—sarcoma	0.0265	0.034	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—sarcoma	0.0223	0.0285	CbGbCtD
Desipramine—CYP1A2—Etoposide—sarcoma	0.0191	0.0245	CbGbCtD
Desipramine—ABCB1—Vincristine—sarcoma	0.0183	0.0234	CbGbCtD
Desipramine—ABCB1—Etoposide—sarcoma	0.0167	0.0214	CbGbCtD
Desipramine—CYP3A4—Mitoxantrone—sarcoma	0.0159	0.0204	CbGbCtD
Desipramine—ABCB1—Doxorubicin—sarcoma	0.0114	0.0146	CbGbCtD
Desipramine—CYP3A4—Vincristine—sarcoma	0.0109	0.014	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—sarcoma	0.0108	0.0138	CbGbCtD
Desipramine—CYP3A4—Etoposide—sarcoma	0.01	0.0128	CbGbCtD
Desipramine—CYP3A4—Doxorubicin—sarcoma	0.00684	0.00876	CbGbCtD
Desipramine—CHRM3—muscle of abdomen—sarcoma	0.00543	0.0747	CbGeAlD
Desipramine—SLC22A4—larynx—sarcoma	0.00453	0.0625	CbGeAlD
Desipramine—HTR2A—pulmonary artery—sarcoma	0.00273	0.0376	CbGeAlD
Desipramine—SMPD1—hematopoietic system—sarcoma	0.0019	0.0262	CbGeAlD
Desipramine—SMPD1—connective tissue—sarcoma	0.00183	0.0252	CbGeAlD
Desipramine—SMPD1—skin of body—sarcoma	0.00165	0.0227	CbGeAlD
Desipramine—HTR2A—hindlimb—sarcoma	0.00165	0.0227	CbGeAlD
Desipramine—SLC22A4—mammary gland—sarcoma	0.00147	0.0202	CbGeAlD
Desipramine—SMPD1—cardiac atrium—sarcoma	0.00144	0.0199	CbGeAlD
Desipramine—HTR2A—appendage—sarcoma	0.00141	0.0195	CbGeAlD
Desipramine—SMPD1—lymphoid tissue—sarcoma	0.00134	0.0184	CbGeAlD
Desipramine—SMPD1—tendon—sarcoma	0.00126	0.0173	CbGeAlD
Desipramine—CHRM5—skin of body—sarcoma	0.0011	0.0151	CbGeAlD
Desipramine—CYP2A6—seminal vesicle—sarcoma	0.00107	0.0148	CbGeAlD
Desipramine—SLC22A4—myometrium—sarcoma	0.00104	0.0144	CbGeAlD
Desipramine—SMPD1—testis—sarcoma	0.00104	0.0143	CbGeAlD
Desipramine—SMPD1—liver—sarcoma	0.000984	0.0136	CbGeAlD
Desipramine—SLC22A5—mammary gland—sarcoma	0.000972	0.0134	CbGeAlD
Desipramine—SLC22A3—myometrium—sarcoma	0.000948	0.0131	CbGeAlD
Desipramine—SLC22A4—seminal vesicle—sarcoma	0.000941	0.013	CbGeAlD
Desipramine—ORM1—hematopoietic system—sarcoma	0.00093	0.0128	CbGeAlD
Desipramine—SLC22A3—embryo—sarcoma	0.000912	0.0126	CbGeAlD
Desipramine—CHRM4—testis—sarcoma	0.000886	0.0122	CbGeAlD
Desipramine—SLC6A3—hematopoietic system—sarcoma	0.000865	0.0119	CbGeAlD
Desipramine—SLC22A3—seminal vesicle—sarcoma	0.000857	0.0118	CbGeAlD
Desipramine—HTR2A—endothelium—sarcoma	0.000854	0.0118	CbGeAlD
Desipramine—SLC22A3—hematopoietic system—sarcoma	0.000814	0.0112	CbGeAlD
Desipramine—CYP2C18—liver—sarcoma	0.000801	0.011	CbGeAlD
Desipramine—SLC6A4—hematopoietic system—sarcoma	0.000793	0.0109	CbGeAlD
Desipramine—ADRB1—connective tissue—sarcoma	0.00079	0.0109	CbGeAlD
Desipramine—SLC22A3—connective tissue—sarcoma	0.000784	0.0108	CbGeAlD
Desipramine—SMPD1—lymph node—sarcoma	0.000754	0.0104	CbGeAlD
Desipramine—SLC22A3—smooth muscle tissue—sarcoma	0.000717	0.00988	CbGeAlD
Desipramine—HTR1A—hematopoietic system—sarcoma	0.000704	0.00969	CbGeAlD
Desipramine—SLC22A5—myometrium—sarcoma	0.00069	0.0095	CbGeAlD
Desipramine—CYP2C19—hematopoietic system—sarcoma	0.000657	0.00905	CbGeAlD
Desipramine—SLC22A5—seminal vesicle—sarcoma	0.000623	0.00858	CbGeAlD
Desipramine—ADRB1—cardiac atrium—sarcoma	0.000623	0.00858	CbGeAlD
Desipramine—CHRM3—smooth muscle tissue—sarcoma	0.000622	0.00857	CbGeAlD
Desipramine—ORM1—bone marrow—sarcoma	0.000596	0.00821	CbGeAlD
Desipramine—SLC22A4—tendon—sarcoma	0.000592	0.00816	CbGeAlD
Desipramine—HRH1—myometrium—sarcoma	0.000585	0.00806	CbGeAlD
Desipramine—Alopecia—Vincristine—sarcoma	0.000577	0.004	CcSEcCtD
Desipramine—Stomatitis—Etoposide—sarcoma	0.000575	0.00398	CcSEcCtD
Desipramine—Jaundice—Etoposide—sarcoma	0.000575	0.00398	CcSEcCtD
Desipramine—Malaise—Dactinomycin—sarcoma	0.000574	0.00398	CcSEcCtD
Desipramine—SLC22A4—bone marrow—sarcoma	0.000574	0.0079	CbGeAlD
Desipramine—Arrhythmia—Mitoxantrone—sarcoma	0.000569	0.00394	CcSEcCtD
Desipramine—Atrioventricular block—Doxorubicin—sarcoma	0.000564	0.00391	CcSEcCtD
Desipramine—Alopecia—Mitoxantrone—sarcoma	0.000562	0.0039	CcSEcCtD
Desipramine—Coordination abnormal—Doxorubicin—sarcoma	0.000557	0.00386	CcSEcCtD
Desipramine—Convulsion—Thiotepa—sarcoma	0.000556	0.00385	CcSEcCtD
Desipramine—Hypertension—Thiotepa—sarcoma	0.000554	0.00384	CcSEcCtD
Desipramine—Agranulocytosis—Etoposide—sarcoma	0.00055	0.00381	CcSEcCtD
Desipramine—Ventricular tachycardia—Doxorubicin—sarcoma	0.000547	0.00379	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Doxorubicin—sarcoma	0.000547	0.00379	CcSEcCtD
Desipramine—Anxiety—Thiotepa—sarcoma	0.000544	0.00377	CcSEcCtD
Desipramine—Dysgeusia—Mitoxantrone—sarcoma	0.000542	0.00376	CcSEcCtD
Desipramine—CYP1A2—hematopoietic system—sarcoma	0.000536	0.00739	CbGeAlD
Desipramine—Discomfort—Dactinomycin—sarcoma	0.000536	0.00371	CcSEcCtD
Desipramine—CYP2A6—liver—sarcoma	0.000529	0.00729	CbGeAlD
Desipramine—Confusional state—Thiotepa—sarcoma	0.000528	0.00366	CcSEcCtD
Desipramine—Hypoaesthesia—Etoposide—sarcoma	0.000527	0.00365	CcSEcCtD
Desipramine—Agitation—Vincristine—sarcoma	0.000523	0.00362	CcSEcCtD
Desipramine—Vision blurred—Mitoxantrone—sarcoma	0.000522	0.00362	CcSEcCtD
Desipramine—Oedema—Dactinomycin—sarcoma	0.00052	0.0036	CcSEcCtD
Desipramine—SLC22A5—skin of body—sarcoma	0.000515	0.00709	CbGeAlD
Desipramine—CYP2B6—hematopoietic system—sarcoma	0.000514	0.00708	CbGeAlD
Desipramine—Ill-defined disorder—Mitoxantrone—sarcoma	0.000514	0.00356	CcSEcCtD
Desipramine—Thrombocytopenia—Thiotepa—sarcoma	0.000513	0.00355	CcSEcCtD
Desipramine—Tachycardia—Thiotepa—sarcoma	0.000511	0.00354	CcSEcCtD
Desipramine—Thrombocytopenia—Dactinomycin—sarcoma	0.000509	0.00353	CcSEcCtD
Desipramine—CYP2E1—seminal vesicle—sarcoma	0.000508	0.00699	CbGeAlD
Desipramine—HRH1—hematopoietic system—sarcoma	0.000502	0.00692	CbGeAlD
Desipramine—Malaise—Mitoxantrone—sarcoma	0.0005	0.00346	CcSEcCtD
Desipramine—Anorexia—Thiotepa—sarcoma	0.000499	0.00346	CcSEcCtD
Desipramine—Anorexia—Dactinomycin—sarcoma	0.000495	0.00343	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.000493	0.00342	CcSEcCtD
Desipramine—Convulsion—Vincristine—sarcoma	0.000493	0.00342	CcSEcCtD
Desipramine—Flushing—Etoposide—sarcoma	0.000491	0.0034	CcSEcCtD
Desipramine—Hypertension—Vincristine—sarcoma	0.000491	0.0034	CcSEcCtD
Desipramine—HRH1—connective tissue—sarcoma	0.000483	0.00666	CbGeAlD
Desipramine—CYP2E1—hematopoietic system—sarcoma	0.000483	0.00665	CbGeAlD
Desipramine—ORM1—liver—sarcoma	0.000482	0.00664	CbGeAlD
Desipramine—Convulsion—Mitoxantrone—sarcoma	0.00048	0.00333	CcSEcCtD
Desipramine—Vascular purpura—Epirubicin—sarcoma	0.000479	0.00332	CcSEcCtD
Desipramine—Hypertension—Mitoxantrone—sarcoma	0.000478	0.00331	CcSEcCtD
Desipramine—SLC6A3—testis—sarcoma	0.000474	0.00653	CbGeAlD
Desipramine—Paraesthesia—Thiotepa—sarcoma	0.00047	0.00326	CcSEcCtD
Desipramine—Anxiety—Mitoxantrone—sarcoma	0.00047	0.00326	CcSEcCtD
Desipramine—HTR2A—embryo—sarcoma	0.00047	0.00647	CbGeAlD
Desipramine—Alopecia—Etoposide—sarcoma	0.000468	0.00324	CcSEcCtD
Desipramine—Discomfort—Mitoxantrone—sarcoma	0.000466	0.00323	CcSEcCtD
Desipramine—Somnolence—Thiotepa—sarcoma	0.000465	0.00323	CcSEcCtD
Desipramine—Oedema—Vincristine—sarcoma	0.000464	0.00322	CcSEcCtD
Desipramine—Dyspepsia—Thiotepa—sarcoma	0.000461	0.00319	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.000456	0.00316	CcSEcCtD
Desipramine—Confusional state—Mitoxantrone—sarcoma	0.000456	0.00316	CcSEcCtD
Desipramine—Decreased appetite—Thiotepa—sarcoma	0.000455	0.00315	CcSEcCtD
Desipramine—Thrombocytopenia—Vincristine—sarcoma	0.000455	0.00315	CcSEcCtD
Desipramine—Oedema—Mitoxantrone—sarcoma	0.000452	0.00313	CcSEcCtD
Desipramine—Decreased appetite—Dactinomycin—sarcoma	0.000452	0.00313	CcSEcCtD
Desipramine—Fatigue—Thiotepa—sarcoma	0.000451	0.00313	CcSEcCtD
Desipramine—Dysgeusia—Etoposide—sarcoma	0.000451	0.00313	CcSEcCtD
Desipramine—SLC22A5—cardiac atrium—sarcoma	0.00045	0.00619	CbGeAlD
Desipramine—Fatigue—Dactinomycin—sarcoma	0.000448	0.0031	CcSEcCtD
Desipramine—Constipation—Thiotepa—sarcoma	0.000448	0.0031	CcSEcCtD
Desipramine—CYP2B6—skin of body—sarcoma	0.000447	0.00616	CbGeAlD
Desipramine—SLC22A3—testis—sarcoma	0.000446	0.00615	CbGeAlD
Desipramine—Purpura—Epirubicin—sarcoma	0.000445	0.00308	CcSEcCtD
Desipramine—Vascular purpura—Doxorubicin—sarcoma	0.000444	0.00307	CcSEcCtD
Desipramine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000443	0.00307	CcSEcCtD
Desipramine—Anorexia—Vincristine—sarcoma	0.000443	0.00307	CcSEcCtD
Desipramine—HRH1—smooth muscle tissue—sarcoma	0.000442	0.00609	CbGeAlD
Desipramine—SLC22A1—liver—sarcoma	0.000441	0.00608	CbGeAlD
Desipramine—Tachycardia—Mitoxantrone—sarcoma	0.000441	0.00306	CcSEcCtD
Desipramine—Cerebrovascular accident—Epirubicin—sarcoma	0.000438	0.00303	CcSEcCtD
Desipramine—Hypotension—Vincristine—sarcoma	0.000434	0.00301	CcSEcCtD
Desipramine—Feeling abnormal—Thiotepa—sarcoma	0.000431	0.00299	CcSEcCtD
Desipramine—Anorexia—Mitoxantrone—sarcoma	0.000431	0.00299	CcSEcCtD
Desipramine—Feeling abnormal—Dactinomycin—sarcoma	0.000428	0.00297	CcSEcCtD
Desipramine—Ill-defined disorder—Etoposide—sarcoma	0.000428	0.00296	CcSEcCtD
Desipramine—Hypotension—Mitoxantrone—sarcoma	0.000422	0.00293	CcSEcCtD
Desipramine—SLC22A3—liver—sarcoma	0.000422	0.00581	CbGeAlD
Desipramine—Insomnia—Vincristine—sarcoma	0.00042	0.00291	CcSEcCtD
Desipramine—HTR2A—hematopoietic system—sarcoma	0.000419	0.00578	CbGeAlD
Desipramine—Paraesthesia—Vincristine—sarcoma	0.000417	0.00289	CcSEcCtD
Desipramine—Urticaria—Thiotepa—sarcoma	0.000416	0.00288	CcSEcCtD
Desipramine—Malaise—Etoposide—sarcoma	0.000416	0.00288	CcSEcCtD
Desipramine—Abdominal pain—Thiotepa—sarcoma	0.000414	0.00287	CcSEcCtD
Desipramine—Body temperature increased—Thiotepa—sarcoma	0.000414	0.00287	CcSEcCtD
Desipramine—Purpura—Doxorubicin—sarcoma	0.000412	0.00285	CcSEcCtD
Desipramine—Abdominal pain—Dactinomycin—sarcoma	0.000411	0.00285	CcSEcCtD
Desipramine—Body temperature increased—Dactinomycin—sarcoma	0.000411	0.00285	CcSEcCtD
Desipramine—Paraesthesia—Mitoxantrone—sarcoma	0.000406	0.00281	CcSEcCtD
Desipramine—Cerebrovascular accident—Doxorubicin—sarcoma	0.000405	0.00281	CcSEcCtD
Desipramine—HTR2A—connective tissue—sarcoma	0.000404	0.00556	CbGeAlD
Desipramine—Decreased appetite—Vincristine—sarcoma	0.000404	0.0028	CcSEcCtD
Desipramine—Ataxia—Epirubicin—sarcoma	0.000403	0.00279	CcSEcCtD
Desipramine—Somnolence—Mitoxantrone—sarcoma	0.000402	0.00279	CcSEcCtD
Desipramine—Fatigue—Vincristine—sarcoma	0.0004	0.00277	CcSEcCtD
Desipramine—Convulsion—Etoposide—sarcoma	0.000399	0.00277	CcSEcCtD
Desipramine—Dyspepsia—Mitoxantrone—sarcoma	0.000398	0.00276	CcSEcCtD
Desipramine—Hypertension—Etoposide—sarcoma	0.000398	0.00276	CcSEcCtD
Desipramine—Constipation—Vincristine—sarcoma	0.000397	0.00275	CcSEcCtD
Desipramine—Liver function test abnormal—Epirubicin—sarcoma	0.000396	0.00274	CcSEcCtD
Desipramine—Decreased appetite—Mitoxantrone—sarcoma	0.000393	0.00272	CcSEcCtD
Desipramine—SLC22A5—tendon—sarcoma	0.000392	0.0054	CbGeAlD
Desipramine—Fatigue—Mitoxantrone—sarcoma	0.00039	0.0027	CcSEcCtD
Desipramine—CYP3A4—hematopoietic system—sarcoma	0.000388	0.00535	CbGeAlD
Desipramine—Discomfort—Etoposide—sarcoma	0.000388	0.00269	CcSEcCtD
Desipramine—CHRM3—testis—sarcoma	0.000387	0.00533	CbGeAlD
Desipramine—Constipation—Mitoxantrone—sarcoma	0.000387	0.00268	CcSEcCtD
Desipramine—SLC6A2—testis—sarcoma	0.000382	0.00527	CbGeAlD
Desipramine—CYP2D6—hematopoietic system—sarcoma	0.000382	0.00526	CbGeAlD
Desipramine—Confusional state—Etoposide—sarcoma	0.000379	0.00263	CcSEcCtD
Desipramine—Asthenia—Thiotepa—sarcoma	0.000376	0.0026	CcSEcCtD
Desipramine—Ataxia—Doxorubicin—sarcoma	0.000373	0.00259	CcSEcCtD
Desipramine—Asthenia—Dactinomycin—sarcoma	0.000373	0.00258	CcSEcCtD
Desipramine—Feeling abnormal—Mitoxantrone—sarcoma	0.000373	0.00258	CcSEcCtD
Desipramine—Pruritus—Thiotepa—sarcoma	0.00037	0.00257	CcSEcCtD
Desipramine—ORM1—lymph node—sarcoma	0.000369	0.00509	CbGeAlD
Desipramine—HTR2A—smooth muscle tissue—sarcoma	0.000369	0.00509	CbGeAlD
Desipramine—Thrombocytopenia—Etoposide—sarcoma	0.000368	0.00255	CcSEcCtD
Desipramine—Tachycardia—Etoposide—sarcoma	0.000367	0.00254	CcSEcCtD
Desipramine—Eosinophilia—Epirubicin—sarcoma	0.000367	0.00254	CcSEcCtD
Desipramine—Abdominal pain—Vincristine—sarcoma	0.000367	0.00254	CcSEcCtD
Desipramine—Body temperature increased—Vincristine—sarcoma	0.000367	0.00254	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—sarcoma	0.000366	0.00254	CcSEcCtD
Desipramine—CYP2B6—lymphoid tissue—sarcoma	0.000362	0.00499	CbGeAlD
Desipramine—Urticaria—Mitoxantrone—sarcoma	0.000359	0.00249	CcSEcCtD
Desipramine—Anorexia—Etoposide—sarcoma	0.000358	0.00248	CcSEcCtD
Desipramine—Diarrhoea—Thiotepa—sarcoma	0.000358	0.00248	CcSEcCtD
Desipramine—Abdominal pain—Mitoxantrone—sarcoma	0.000357	0.00248	CcSEcCtD
Desipramine—Body temperature increased—Mitoxantrone—sarcoma	0.000357	0.00248	CcSEcCtD
Desipramine—Diarrhoea—Dactinomycin—sarcoma	0.000356	0.00246	CcSEcCtD
Desipramine—SLC22A4—lymph node—sarcoma	0.000355	0.0049	CbGeAlD
Desipramine—Hypotension—Etoposide—sarcoma	0.000351	0.00244	CcSEcCtD
Desipramine—DRD2—testis—sarcoma	0.000348	0.0048	CbGeAlD
Desipramine—Dizziness—Thiotepa—sarcoma	0.000346	0.0024	CcSEcCtD
Desipramine—Pollakiuria—Epirubicin—sarcoma	0.000342	0.00237	CcSEcCtD
Desipramine—CYP2C19—liver—sarcoma	0.00034	0.00469	CbGeAlD
Desipramine—CYP2E1—lymphoid tissue—sarcoma	0.00034	0.00468	CbGeAlD
Desipramine—Eosinophilia—Doxorubicin—sarcoma	0.00034	0.00235	CcSEcCtD
Desipramine—Paraesthesia—Etoposide—sarcoma	0.000338	0.00234	CcSEcCtD
Desipramine—Weight increased—Epirubicin—sarcoma	0.000337	0.00234	CcSEcCtD
Desipramine—Somnolence—Etoposide—sarcoma	0.000334	0.00232	CcSEcCtD
Desipramine—Asthenia—Vincristine—sarcoma	0.000333	0.00231	CcSEcCtD
Desipramine—Vomiting—Thiotepa—sarcoma	0.000333	0.00231	CcSEcCtD
Desipramine—HRH1—tendon—sarcoma	0.000332	0.00458	CbGeAlD
Desipramine—Drowsiness—Epirubicin—sarcoma	0.000331	0.00229	CcSEcCtD
Desipramine—Vomiting—Dactinomycin—sarcoma	0.00033	0.00229	CcSEcCtD
Desipramine—Rash—Thiotepa—sarcoma	0.00033	0.00229	CcSEcCtD
Desipramine—Dermatitis—Thiotepa—sarcoma	0.00033	0.00229	CcSEcCtD
Desipramine—Headache—Thiotepa—sarcoma	0.000328	0.00227	CcSEcCtD
Desipramine—Rash—Dactinomycin—sarcoma	0.000328	0.00227	CcSEcCtD
Desipramine—Decreased appetite—Etoposide—sarcoma	0.000327	0.00227	CcSEcCtD
Desipramine—SLC22A5—testis—sarcoma	0.000324	0.00447	CbGeAlD
Desipramine—Asthenia—Mitoxantrone—sarcoma	0.000324	0.00225	CcSEcCtD
Desipramine—Fatigue—Etoposide—sarcoma	0.000324	0.00225	CcSEcCtD
Desipramine—Neuropathy peripheral—Epirubicin—sarcoma	0.000324	0.00225	CcSEcCtD
Desipramine—SLC22A3—lymph node—sarcoma	0.000323	0.00446	CbGeAlD
Desipramine—Jaundice—Epirubicin—sarcoma	0.000322	0.00223	CcSEcCtD
Desipramine—Stomatitis—Epirubicin—sarcoma	0.000322	0.00223	CcSEcCtD
Desipramine—Constipation—Etoposide—sarcoma	0.000322	0.00223	CcSEcCtD
Desipramine—ABCB1—myometrium—sarcoma	0.00032	0.00441	CbGeAlD
Desipramine—CYP2E1—tendon—sarcoma	0.000319	0.0044	CbGeAlD
Desipramine—Diarrhoea—Vincristine—sarcoma	0.000318	0.0022	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—sarcoma	0.000317	0.0022	CcSEcCtD
Desipramine—Weight increased—Doxorubicin—sarcoma	0.000312	0.00216	CcSEcCtD
Desipramine—Nausea—Thiotepa—sarcoma	0.000311	0.00215	CcSEcCtD
Desipramine—Feeling abnormal—Etoposide—sarcoma	0.00031	0.00215	CcSEcCtD
Desipramine—Diarrhoea—Mitoxantrone—sarcoma	0.000309	0.00214	CcSEcCtD
Desipramine—Nausea—Dactinomycin—sarcoma	0.000309	0.00214	CcSEcCtD
Desipramine—Agranulocytosis—Epirubicin—sarcoma	0.000308	0.00214	CcSEcCtD
Desipramine—ABCB1—embryo—sarcoma	0.000308	0.00424	CbGeAlD
Desipramine—Dizziness—Vincristine—sarcoma	0.000307	0.00213	CcSEcCtD
Desipramine—SLC22A5—liver—sarcoma	0.000307	0.00423	CbGeAlD
Desipramine—Drowsiness—Doxorubicin—sarcoma	0.000306	0.00212	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—sarcoma	0.0003	0.00208	CcSEcCtD
Desipramine—Urticaria—Etoposide—sarcoma	0.000299	0.00207	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—sarcoma	0.000298	0.00207	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—sarcoma	0.000298	0.00207	CcSEcCtD
Desipramine—Body temperature increased—Etoposide—sarcoma	0.000297	0.00206	CcSEcCtD
Desipramine—Abdominal pain—Etoposide—sarcoma	0.000297	0.00206	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—sarcoma	0.000297	0.00206	CcSEcCtD
Desipramine—Hypoaesthesia—Epirubicin—sarcoma	0.000295	0.00205	CcSEcCtD
Desipramine—Vomiting—Vincristine—sarcoma	0.000295	0.00205	CcSEcCtD
Desipramine—Rash—Vincristine—sarcoma	0.000293	0.00203	CcSEcCtD
Desipramine—Dermatitis—Vincristine—sarcoma	0.000292	0.00203	CcSEcCtD
Desipramine—Headache—Vincristine—sarcoma	0.000291	0.00202	CcSEcCtD
Desipramine—ABCB1—seminal vesicle—sarcoma	0.000289	0.00398	CbGeAlD
Desipramine—Vomiting—Mitoxantrone—sarcoma	0.000287	0.00199	CcSEcCtD
Desipramine—Agranulocytosis—Doxorubicin—sarcoma	0.000285	0.00198	CcSEcCtD
Desipramine—Rash—Mitoxantrone—sarcoma	0.000285	0.00198	CcSEcCtD
Desipramine—Dermatitis—Mitoxantrone—sarcoma	0.000285	0.00197	CcSEcCtD
Desipramine—Headache—Mitoxantrone—sarcoma	0.000283	0.00196	CcSEcCtD
Desipramine—CYP2B6—testis—sarcoma	0.000282	0.00388	CbGeAlD
Desipramine—CYP1A2—liver—sarcoma	0.000278	0.00383	CbGeAlD
Desipramine—HTR2A—tendon—sarcoma	0.000278	0.00382	CbGeAlD
Desipramine—SLC6A2—lymph node—sarcoma	0.000277	0.00382	CbGeAlD
Desipramine—Tinnitus—Epirubicin—sarcoma	0.000277	0.00192	CcSEcCtD
Desipramine—Nausea—Vincristine—sarcoma	0.000276	0.00191	CcSEcCtD
Desipramine—Flushing—Epirubicin—sarcoma	0.000275	0.00191	CcSEcCtD
Desipramine—HRH1—testis—sarcoma	0.000275	0.00379	CbGeAlD
Desipramine—ABCB1—hematopoietic system—sarcoma	0.000275	0.00379	CbGeAlD
Desipramine—Hepatitis—Doxorubicin—sarcoma	0.000275	0.0019	CcSEcCtD
Desipramine—Hypoaesthesia—Doxorubicin—sarcoma	0.000273	0.00189	CcSEcCtD
Desipramine—Asthenia—Etoposide—sarcoma	0.00027	0.00187	CcSEcCtD
Desipramine—Nausea—Mitoxantrone—sarcoma	0.000269	0.00186	CcSEcCtD
Desipramine—CYP2B6—liver—sarcoma	0.000266	0.00367	CbGeAlD
Desipramine—Pruritus—Etoposide—sarcoma	0.000266	0.00184	CcSEcCtD
Desipramine—Arrhythmia—Epirubicin—sarcoma	0.000265	0.00184	CcSEcCtD
Desipramine—CYP2E1—testis—sarcoma	0.000264	0.00364	CbGeAlD
Desipramine—Alopecia—Epirubicin—sarcoma	0.000262	0.00182	CcSEcCtD
Desipramine—Diarrhoea—Etoposide—sarcoma	0.000257	0.00178	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—sarcoma	0.000256	0.00177	CcSEcCtD
Desipramine—Flushing—Doxorubicin—sarcoma	0.000255	0.00177	CcSEcCtD
Desipramine—Dysgeusia—Epirubicin—sarcoma	0.000253	0.00175	CcSEcCtD
Desipramine—CYP2E1—liver—sarcoma	0.00025	0.00344	CbGeAlD
Desipramine—Dizziness—Etoposide—sarcoma	0.000249	0.00172	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—sarcoma	0.000245	0.0017	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—sarcoma	0.000243	0.00169	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—sarcoma	0.000243	0.00168	CcSEcCtD
Desipramine—Ill-defined disorder—Epirubicin—sarcoma	0.00024	0.00166	CcSEcCtD
Desipramine—Vomiting—Etoposide—sarcoma	0.000239	0.00166	CcSEcCtD
Desipramine—Agitation—Epirubicin—sarcoma	0.000237	0.00164	CcSEcCtD
Desipramine—Rash—Etoposide—sarcoma	0.000237	0.00164	CcSEcCtD
Desipramine—Dermatitis—Etoposide—sarcoma	0.000237	0.00164	CcSEcCtD
Desipramine—Headache—Etoposide—sarcoma	0.000236	0.00163	CcSEcCtD
Desipramine—SLC22A5—lymph node—sarcoma	0.000235	0.00324	CbGeAlD
Desipramine—Dysgeusia—Doxorubicin—sarcoma	0.000234	0.00162	CcSEcCtD
Desipramine—Malaise—Epirubicin—sarcoma	0.000233	0.00161	CcSEcCtD
Desipramine—HTR2A—testis—sarcoma	0.00023	0.00317	CbGeAlD
Desipramine—Palpitations—Epirubicin—sarcoma	0.000228	0.00158	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—sarcoma	0.000225	0.00156	CcSEcCtD
Desipramine—Convulsion—Epirubicin—sarcoma	0.000224	0.00155	CcSEcCtD
Desipramine—Nausea—Etoposide—sarcoma	0.000223	0.00155	CcSEcCtD
Desipramine—Hypertension—Epirubicin—sarcoma	0.000223	0.00155	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—sarcoma	0.000222	0.00154	CcSEcCtD
Desipramine—Agitation—Doxorubicin—sarcoma	0.00022	0.00152	CcSEcCtD
Desipramine—Anxiety—Epirubicin—sarcoma	0.000219	0.00152	CcSEcCtD
Desipramine—HTR2A—liver—sarcoma	0.000217	0.00299	CbGeAlD
Desipramine—Discomfort—Epirubicin—sarcoma	0.000217	0.00151	CcSEcCtD
Desipramine—Malaise—Doxorubicin—sarcoma	0.000216	0.00149	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—sarcoma	0.000215	0.00149	CcSEcCtD
Desipramine—Confusional state—Epirubicin—sarcoma	0.000213	0.00147	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—sarcoma	0.000211	0.00146	CcSEcCtD
Desipramine—Oedema—Epirubicin—sarcoma	0.000211	0.00146	CcSEcCtD
Desipramine—CYP2D6—testis—sarcoma	0.000209	0.00288	CbGeAlD
Desipramine—ABCB1—uterus—sarcoma	0.000208	0.00286	CbGeAlD
Desipramine—Convulsion—Doxorubicin—sarcoma	0.000207	0.00143	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—sarcoma	0.000206	0.00143	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—sarcoma	0.000206	0.00143	CcSEcCtD
Desipramine—Tachycardia—Epirubicin—sarcoma	0.000206	0.00143	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—sarcoma	0.000203	0.00141	CcSEcCtD
Desipramine—CYP3A4—liver—sarcoma	0.000201	0.00277	CbGeAlD
Desipramine—Discomfort—Doxorubicin—sarcoma	0.000201	0.00139	CcSEcCtD
Desipramine—Anorexia—Epirubicin—sarcoma	0.000201	0.00139	CcSEcCtD
Desipramine—HRH1—lymph node—sarcoma	0.000199	0.00275	CbGeAlD
Desipramine—Dry mouth—Doxorubicin—sarcoma	0.000199	0.00138	CcSEcCtD
Desipramine—CYP2D6—liver—sarcoma	0.000198	0.00273	CbGeAlD
Desipramine—Hypotension—Epirubicin—sarcoma	0.000197	0.00137	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—sarcoma	0.000197	0.00136	CcSEcCtD
Desipramine—Oedema—Doxorubicin—sarcoma	0.000195	0.00135	CcSEcCtD
Desipramine—ABCB1—lymphoid tissue—sarcoma	0.000193	0.00267	CbGeAlD
Desipramine—Thrombocytopenia—Doxorubicin—sarcoma	0.000191	0.00132	CcSEcCtD
Desipramine—Insomnia—Epirubicin—sarcoma	0.000191	0.00132	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—sarcoma	0.00019	0.00132	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—sarcoma	0.000189	0.00131	CcSEcCtD
Desipramine—Somnolence—Epirubicin—sarcoma	0.000187	0.0013	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—sarcoma	0.000186	0.00129	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—sarcoma	0.000186	0.00129	CcSEcCtD
Desipramine—Decreased appetite—Epirubicin—sarcoma	0.000183	0.00127	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—sarcoma	0.000182	0.00126	CcSEcCtD
Desipramine—Fatigue—Epirubicin—sarcoma	0.000182	0.00126	CcSEcCtD
Desipramine—Constipation—Epirubicin—sarcoma	0.00018	0.00125	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—sarcoma	0.000176	0.00122	CcSEcCtD
Desipramine—ABCB1—bone marrow—sarcoma	0.000176	0.00243	CbGeAlD
Desipramine—Paraesthesia—Doxorubicin—sarcoma	0.000175	0.00121	CcSEcCtD
Desipramine—Feeling abnormal—Epirubicin—sarcoma	0.000174	0.0012	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—sarcoma	0.000173	0.0012	CcSEcCtD
Desipramine—Dyspepsia—Doxorubicin—sarcoma	0.000172	0.00119	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—sarcoma	0.00017	0.00117	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—sarcoma	0.000168	0.00117	CcSEcCtD
Desipramine—Urticaria—Epirubicin—sarcoma	0.000167	0.00116	CcSEcCtD
Desipramine—Constipation—Doxorubicin—sarcoma	0.000167	0.00116	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—sarcoma	0.000167	0.00115	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—sarcoma	0.000167	0.00115	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—sarcoma	0.000161	0.00111	CcSEcCtD
Desipramine—Urticaria—Doxorubicin—sarcoma	0.000155	0.00107	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—sarcoma	0.000154	0.00107	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—sarcoma	0.000154	0.00107	CcSEcCtD
Desipramine—Asthenia—Epirubicin—sarcoma	0.000151	0.00105	CcSEcCtD
Desipramine—ABCB1—testis—sarcoma	0.000151	0.00207	CbGeAlD
Desipramine—Pruritus—Epirubicin—sarcoma	0.000149	0.00103	CcSEcCtD
Desipramine—Diarrhoea—Epirubicin—sarcoma	0.000144	0.000999	CcSEcCtD
Desipramine—ABCB1—liver—sarcoma	0.000142	0.00196	CbGeAlD
Desipramine—Asthenia—Doxorubicin—sarcoma	0.00014	0.00097	CcSEcCtD
Desipramine—Dizziness—Epirubicin—sarcoma	0.000139	0.000966	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—sarcoma	0.000138	0.000956	CcSEcCtD
Desipramine—Vomiting—Epirubicin—sarcoma	0.000134	0.000929	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—sarcoma	0.000133	0.000925	CcSEcCtD
Desipramine—Rash—Epirubicin—sarcoma	0.000133	0.000921	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—sarcoma	0.000133	0.00092	CcSEcCtD
Desipramine—Headache—Epirubicin—sarcoma	0.000132	0.000915	CcSEcCtD
Desipramine—Dizziness—Doxorubicin—sarcoma	0.000129	0.000894	CcSEcCtD
Desipramine—Nausea—Epirubicin—sarcoma	0.000125	0.000868	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—sarcoma	0.000124	0.000859	CcSEcCtD
Desipramine—Rash—Doxorubicin—sarcoma	0.000123	0.000852	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—sarcoma	0.000123	0.000851	CcSEcCtD
Desipramine—Headache—Doxorubicin—sarcoma	0.000122	0.000847	CcSEcCtD
Desipramine—Nausea—Doxorubicin—sarcoma	0.000116	0.000803	CcSEcCtD
Desipramine—ABCB1—lymph node—sarcoma	0.000109	0.0015	CbGeAlD
Desipramine—CHRM3—GPCR downstream signaling—IL2—sarcoma	6.13e-07	0.000318	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PDGFRB—sarcoma	6.12e-07	0.000318	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PDGFRA—sarcoma	6.08e-07	0.000316	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—FOXO1—sarcoma	6.07e-07	0.000316	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—IL2—sarcoma	6.07e-07	0.000315	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—EGFR—sarcoma	6.06e-07	0.000315	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PDGFRA—sarcoma	6.06e-07	0.000315	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PDGFRB—sarcoma	6.06e-07	0.000315	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KDR—sarcoma	6.05e-07	0.000315	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PDGFRA—sarcoma	6.04e-07	0.000314	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PDGFRA—sarcoma	6.02e-07	0.000313	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—KRAS—sarcoma	5.98e-07	0.000311	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PDGFRA—sarcoma	5.97e-07	0.00031	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KDR—sarcoma	5.92e-07	0.000308	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KDR—sarcoma	5.89e-07	0.000306	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—KRAS—sarcoma	5.73e-07	0.000298	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL2—sarcoma	5.7e-07	0.000296	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KIT—sarcoma	5.7e-07	0.000296	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—NRAS—sarcoma	5.7e-07	0.000296	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL2—sarcoma	5.61e-07	0.000292	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL2—sarcoma	5.6e-07	0.000291	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL2—sarcoma	5.58e-07	0.00029	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KIT—sarcoma	5.58e-07	0.00029	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—NRAS—sarcoma	5.58e-07	0.00029	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL2—sarcoma	5.56e-07	0.000289	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL2—sarcoma	5.51e-07	0.000286	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MDM2—sarcoma	5.47e-07	0.000284	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KIT—sarcoma	5.45e-07	0.000283	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—NRAS—sarcoma	5.45e-07	0.000283	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CREB1—sarcoma	5.43e-07	0.000282	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KIT—sarcoma	5.43e-07	0.000282	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—NRAS—sarcoma	5.43e-07	0.000282	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CREB1—sarcoma	5.31e-07	0.000276	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MDM2—sarcoma	5.24e-07	0.000272	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PLCG1—sarcoma	5.23e-07	0.000272	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KDR—sarcoma	5.2e-07	0.00027	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—EGFR—sarcoma	5.19e-07	0.00027	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CREB1—sarcoma	5.19e-07	0.00027	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CREB1—sarcoma	5.16e-07	0.000268	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KDR—sarcoma	5.11e-07	0.000266	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KDR—sarcoma	5.1e-07	0.000265	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KDR—sarcoma	5.09e-07	0.000264	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—HRAS—sarcoma	5.08e-07	0.000264	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—EGFR—sarcoma	5.08e-07	0.000264	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KDR—sarcoma	5.07e-07	0.000264	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KDR—sarcoma	5.02e-07	0.000261	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—EGFR—sarcoma	4.97e-07	0.000258	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—EGFR—sarcoma	4.94e-07	0.000257	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—KRAS—sarcoma	4.91e-07	0.000255	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL2—sarcoma	4.89e-07	0.000254	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—HRAS—sarcoma	4.87e-07	0.000253	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—KRAS—sarcoma	4.8e-07	0.000249	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KIT—sarcoma	4.79e-07	0.000249	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—NRAS—sarcoma	4.79e-07	0.000249	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CCND1—sarcoma	4.77e-07	0.000248	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ENO2—sarcoma	4.76e-07	0.000247	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—JUN—sarcoma	4.76e-07	0.000247	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HBA1—sarcoma	4.73e-07	0.000246	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CTNNB1—sarcoma	4.72e-07	0.000245	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KIT—sarcoma	4.71e-07	0.000245	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—NRAS—sarcoma	4.71e-07	0.000245	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KIT—sarcoma	4.7e-07	0.000244	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—NRAS—sarcoma	4.7e-07	0.000244	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—KRAS—sarcoma	4.69e-07	0.000244	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KIT—sarcoma	4.69e-07	0.000244	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—NRAS—sarcoma	4.69e-07	0.000244	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL2—sarcoma	4.68e-07	0.000243	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KIT—sarcoma	4.67e-07	0.000243	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—NRAS—sarcoma	4.67e-07	0.000243	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—KRAS—sarcoma	4.67e-07	0.000243	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KIT—sarcoma	4.63e-07	0.00024	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—NRAS—sarcoma	4.63e-07	0.00024	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CCND1—sarcoma	4.57e-07	0.000237	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CREB1—sarcoma	4.56e-07	0.000237	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—JUN—sarcoma	4.56e-07	0.000237	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CTNNB1—sarcoma	4.52e-07	0.000235	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MDM2—sarcoma	4.49e-07	0.000233	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CREB1—sarcoma	4.48e-07	0.000233	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CREB1—sarcoma	4.47e-07	0.000233	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CREB1—sarcoma	4.46e-07	0.000232	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CREB1—sarcoma	4.45e-07	0.000231	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CREB1—sarcoma	4.4e-07	0.000229	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MDM2—sarcoma	4.39e-07	0.000228	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—EGFR—sarcoma	4.36e-07	0.000227	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MDM2—sarcoma	4.29e-07	0.000223	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—EGFR—sarcoma	4.29e-07	0.000223	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—EGFR—sarcoma	4.28e-07	0.000223	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MDM2—sarcoma	4.27e-07	0.000222	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—EGFR—sarcoma	4.27e-07	0.000222	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—SRC—sarcoma	4.27e-07	0.000222	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—EGFR—sarcoma	4.26e-07	0.000221	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—EGFR—sarcoma	4.21e-07	0.000219	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—HRAS—sarcoma	4.17e-07	0.000217	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—VEGFA—sarcoma	4.16e-07	0.000216	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—KRAS—sarcoma	4.12e-07	0.000214	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—NRAS—sarcoma	4.11e-07	0.000213	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—SRC—sarcoma	4.09e-07	0.000212	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—HRAS—sarcoma	4.08e-07	0.000212	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—KRAS—sarcoma	4.05e-07	0.000211	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—KRAS—sarcoma	4.05e-07	0.00021	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PLCG1—sarcoma	4.04e-07	0.00021	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—KRAS—sarcoma	4.03e-07	0.00021	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—KRAS—sarcoma	4.02e-07	0.000209	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL2—sarcoma	4.01e-07	0.000209	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—HRAS—sarcoma	3.99e-07	0.000207	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—KRAS—sarcoma	3.98e-07	0.000207	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—VEGFA—sarcoma	3.98e-07	0.000207	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—HRAS—sarcoma	3.97e-07	0.000206	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—NRAS—sarcoma	3.93e-07	0.000204	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL2—sarcoma	3.92e-07	0.000204	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CCND1—sarcoma	3.91e-07	0.000203	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—JUN—sarcoma	3.9e-07	0.000203	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CTNNB1—sarcoma	3.87e-07	0.000201	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL2—sarcoma	3.84e-07	0.000199	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CCND1—sarcoma	3.83e-07	0.000199	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MYC—sarcoma	3.82e-07	0.000199	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—JUN—sarcoma	3.82e-07	0.000198	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL2—sarcoma	3.82e-07	0.000198	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CTNNB1—sarcoma	3.79e-07	0.000197	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MDM2—sarcoma	3.77e-07	0.000196	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CCND1—sarcoma	3.74e-07	0.000194	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EGFR—sarcoma	3.74e-07	0.000194	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—JUN—sarcoma	3.73e-07	0.000194	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CCND1—sarcoma	3.72e-07	0.000193	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—JUN—sarcoma	3.71e-07	0.000193	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MDM2—sarcoma	3.71e-07	0.000193	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CTNNB1—sarcoma	3.7e-07	0.000193	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MDM2—sarcoma	3.7e-07	0.000192	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MDM2—sarcoma	3.69e-07	0.000192	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CTNNB1—sarcoma	3.69e-07	0.000192	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MDM2—sarcoma	3.68e-07	0.000191	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MYC—sarcoma	3.66e-07	0.00019	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MDM2—sarcoma	3.64e-07	0.000189	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EGFR—sarcoma	3.58e-07	0.000186	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—KRAS—sarcoma	3.53e-07	0.000184	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HRAS—sarcoma	3.5e-07	0.000182	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SRC—sarcoma	3.5e-07	0.000182	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—HRAS—sarcoma	3.45e-07	0.000179	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HRAS—sarcoma	3.44e-07	0.000179	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HRAS—sarcoma	3.43e-07	0.000178	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SRC—sarcoma	3.42e-07	0.000178	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HRAS—sarcoma	3.42e-07	0.000178	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—sarcoma	3.41e-07	0.000177	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HRAS—sarcoma	3.38e-07	0.000176	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—KRAS—sarcoma	3.38e-07	0.000176	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL2—sarcoma	3.37e-07	0.000175	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NRAS—sarcoma	3.37e-07	0.000175	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SRC—sarcoma	3.35e-07	0.000174	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—sarcoma	3.34e-07	0.000173	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SRC—sarcoma	3.33e-07	0.000173	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL2—sarcoma	3.32e-07	0.000172	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL2—sarcoma	3.31e-07	0.000172	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL2—sarcoma	3.3e-07	0.000171	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NRAS—sarcoma	3.29e-07	0.000171	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL2—sarcoma	3.29e-07	0.000171	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—sarcoma	3.28e-07	0.000171	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—JUN—sarcoma	3.28e-07	0.00017	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—sarcoma	3.26e-07	0.00017	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL2—sarcoma	3.26e-07	0.000169	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CTNNB1—sarcoma	3.25e-07	0.000169	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—sarcoma	3.24e-07	0.000169	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—sarcoma	3.23e-07	0.000168	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—JUN—sarcoma	3.23e-07	0.000168	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—sarcoma	3.22e-07	0.000168	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NRAS—sarcoma	3.22e-07	0.000167	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—JUN—sarcoma	3.22e-07	0.000167	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—sarcoma	3.21e-07	0.000167	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—JUN—sarcoma	3.21e-07	0.000167	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NRAS—sarcoma	3.2e-07	0.000167	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—sarcoma	3.2e-07	0.000167	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CTNNB1—sarcoma	3.2e-07	0.000166	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—JUN—sarcoma	3.2e-07	0.000166	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CTNNB1—sarcoma	3.19e-07	0.000166	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CTNNB1—sarcoma	3.18e-07	0.000165	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—sarcoma	3.17e-07	0.000165	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CTNNB1—sarcoma	3.17e-07	0.000165	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—JUN—sarcoma	3.17e-07	0.000165	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CTNNB1—sarcoma	3.14e-07	0.000163	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—sarcoma	3.14e-07	0.000163	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—sarcoma	3.14e-07	0.000163	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—sarcoma	3.07e-07	0.00016	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—sarcoma	3.07e-07	0.000159	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—sarcoma	3.01e-07	0.000156	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—sarcoma	3e-07	0.000156	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—sarcoma	3e-07	0.000156	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—sarcoma	3e-07	0.000156	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—sarcoma	2.99e-07	0.000155	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SRC—sarcoma	2.94e-07	0.000153	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—sarcoma	2.94e-07	0.000153	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—sarcoma	2.92e-07	0.000152	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—sarcoma	2.9e-07	0.000151	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SRC—sarcoma	2.89e-07	0.00015	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SRC—sarcoma	2.89e-07	0.00015	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SRC—sarcoma	2.88e-07	0.00015	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—sarcoma	2.88e-07	0.000149	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SRC—sarcoma	2.87e-07	0.000149	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—sarcoma	2.86e-07	0.000149	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SRC—sarcoma	2.84e-07	0.000148	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—sarcoma	2.84e-07	0.000147	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRAS—sarcoma	2.83e-07	0.000147	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—sarcoma	2.82e-07	0.000146	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—sarcoma	2.81e-07	0.000146	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—sarcoma	2.8e-07	0.000146	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—sarcoma	2.79e-07	0.000145	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRAS—sarcoma	2.78e-07	0.000145	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRAS—sarcoma	2.78e-07	0.000144	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—sarcoma	2.77e-07	0.000144	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRAS—sarcoma	2.77e-07	0.000144	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—sarcoma	2.77e-07	0.000144	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRAS—sarcoma	2.76e-07	0.000143	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—sarcoma	2.76e-07	0.000143	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRAS—sarcoma	2.73e-07	0.000142	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—sarcoma	2.63e-07	0.000137	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—sarcoma	2.59e-07	0.000135	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—sarcoma	2.59e-07	0.000134	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—sarcoma	2.58e-07	0.000134	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—sarcoma	2.58e-07	0.000134	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—sarcoma	2.58e-07	0.000134	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—sarcoma	2.57e-07	0.000134	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—sarcoma	2.55e-07	0.000132	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—sarcoma	2.54e-07	0.000132	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—sarcoma	2.53e-07	0.000132	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—sarcoma	2.52e-07	0.000131	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—sarcoma	2.52e-07	0.000131	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—sarcoma	2.51e-07	0.000131	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—sarcoma	2.49e-07	0.000129	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—sarcoma	2.46e-07	0.000128	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—sarcoma	2.46e-07	0.000128	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—sarcoma	2.45e-07	0.000127	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—sarcoma	2.43e-07	0.000127	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—sarcoma	2.41e-07	0.000125	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—sarcoma	2.4e-07	0.000124	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—sarcoma	2.39e-07	0.000124	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—sarcoma	2.38e-07	0.000124	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—sarcoma	2.37e-07	0.000123	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—sarcoma	2.36e-07	0.000122	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—sarcoma	2.35e-07	0.000122	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—sarcoma	2.34e-07	0.000122	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—sarcoma	2.16e-07	0.000112	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—sarcoma	2.13e-07	0.000111	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—sarcoma	2.12e-07	0.00011	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—sarcoma	2.12e-07	0.00011	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—sarcoma	2.11e-07	0.00011	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—sarcoma	2.09e-07	0.000109	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—sarcoma	2.07e-07	0.000108	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—sarcoma	2.04e-07	0.000106	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—sarcoma	2.03e-07	0.000106	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—sarcoma	2.03e-07	0.000105	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—sarcoma	2.02e-07	0.000105	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—sarcoma	2e-07	0.000104	CbGpPWpGaD
